Related Experiment Video
Updated: Jan 19, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
[Gastric intestinal metaplasia and cancer risk: how to follow ?]
Stefano Guglielmi1, Fabrizia D'Angelo1, Philippe Bichard1
1Service de gastroentérologie et hépatologie, HUG, 1211 Genève 14.
Abstract:
In 2019, gastric cancer still has high mortality. Gastric intestinal metaplasia (IGM) is an intermediate step in the process of carcinogenesis of intestinal adenocarcinoma. Gastroscopy with biopsies can detect the presence of MIG. Characterization in terms of intensity and distribution allows to stratify the risks and to target the population in which surveillance endoscopies are indicated for the purpose of detecting endoscopic resectable neoplasia in endoscopy.
Related Concept Videos
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
06:36Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue
08:16Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture
03:21Acinar-to-Ductal Metaplasia Induction: A Method to Study Acinar Cell to Ductal Cell Differentiation in 3D Ex Vivo Culture
09:36Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
08:42Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

